Unexpectedly, the tumoral oncogene Mycn and its associated targets were also significantly downregulated (p < 0.0001), which is known to decrease tumor cell proliferation and increase immunogenicity and immune cell infiltration (Fig. 4c,d)26,27. This evidence concerns the gene MYCN and neoplasm.